Vaccine Insight Hub

Vaccine safety assessments in pregnancy blend platform-specific requirements with real-world monitoring.

• General needs for newer platforms include...

Two decades of monitoring show HPV vaccines have a favorable safety profile across more than 160 studies and 100 million U.S. doses.

• Common...

Pharmacy Times surfaces timely clinical insights across multiple vaccines.

• Influenza vaccines cut hospitalizations and deaths in high-risk groups...

The Oswego County Health Department stresses that staying up to date on MMR vaccines is the most effective way to protect individuals and the...

Pennsylvania's measles surge shows why vaccination matters now.

• Over 4,000 U.S. cases this year mark the largest outbreak in 35 years, with...

Black Americans received flu vaccines at lower rates (38%) than white Americans (45.6%) last season. Clinicians can close gaps by focusing on personal...

The CHMP recommended expanding Pandemic influenza vaccine H5N1 AstraZeneca to active immunisation against influenza in any officially declared...

Updated recommendations specify doses by age group:

• Adults 19-64: Receive one dose of the COVID-19 vaccine.
• Adults 65+: Receive two doses of the updated vaccine.
  Recipients should follow these age-based schedules for the 2026-27 season.

mRNA vaccines and other emerging platforms are creating fresh opportunities to tackle the immunological challenges of dengue vaccine development, driven by progress in molecular immunology and vaccine engineering.

Vaccines reduce antibiotic use by preventing bacterial infections and curbing inappropriate prescriptions for viral illnesses.

• Bacterial vaccines...

Parents of children with congenital heart disease showed lower vaccine hesitancy than parents of healthy children, with higher hesitancy only among...

The COVID-19 pandemic showed that equitable access to safe, effective and affordable vaccines, therapeutics and diagnostics depends on more than availability alone, a critical insight for WHO South-East Asia’s future pandemic preparedness.

The Vaccines for Children program has delivered 73 million doses in 2024 alone and prevented over 500 million illnesses since 1994 by removing cost...

Federal moves to weaken the Vaccine Injury Compensation Program risk repeating 1980s supply crises.

• Core threat: Removing vaccines or adding...

October timing helps build protection before peak flu season. Everyone 6 months and older should get the flu vaccine unless medically advised...

Regulatory documents and EMA correspondence reveal serious failures in the conduct and oversight of Pfizer’s pivotal phase III COVID-19 vaccine trial...

The JYNNEOS vaccine for mpox commonly causes tiredness, headache, and muscle pain, along with injection-site reactions including redness, swelling, soreness, and itchiness.

The PubMed source on safety of the 20-valent pneumococcal conjugate vaccine requires cookies to view any details.

Official coverage figures may underestimate missed immunizations due to severe sub-notification, with 67.5% zero doses for hepatitis A and 92.8% for meningococcal ACWY in the study.

mRNA COVID-19 vaccines may heighten tumor responsiveness to immunotherapy and lower death risk in some patients, per a recent study. These results are preliminary suggestions only, with no established clinical benefit confirmed yet.